Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Colombo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Recenti Progressi in Medicina|June 27, 2022
[The TAILOR study establishes, in patients mCRC wt, the first line use of FOLFOX in combination with cetuximab]Alfredo Colombo, Gerardo Rosati, Concetta Maria Porretto
In Vivo (Athens, Greece)|February 27, 2026
Appendiceal Tumors: A Narrative ReviewAlfredo Colombo, Vittorio Gebbia, Maria Rosaria Valerio
In Vivo (Athens, Greece)|December 31, 2024
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF MutationAlfredo Colombo, Porretto Maria Concetta, Vittorio Gebbia, et al.
Journal of Clinical Medicine|December 11, 2022
An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal CancerGerardo Rosati, Michele Montrone, Carmen Pacilio, et al.
Oncology|August 21, 2002
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigationVittorio Gebbia, Gaetano Mauceri, Giuseppina Fallica, et al.
Breast Cancer Research and Treatment|February 27, 2003
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinomaVittorio Gebbia, Nicolò Borsellino, Antonio Testa, et al.
Mediators of Inflammation|July 26, 2002
In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytesGabriele Di Lorenzo, Maria Luisa Pacor, Maria Esposito Pellitteri, et al.
Biomedicines|May 28, 2022
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy EfficacyGerardo Rosati, Giuseppe Aprile, Alfredo Colombo, et al.
Mechanisms of Ageing and Development|April 26, 2003
A study of age-related IgE pathophysiological changesGabriele Di Lorenzo, Maria Luisa Pacor, Maria Esposito Pellitteri, et al.
Journal of Geriatric Oncology|October 30, 2021
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT studyGerardo Rosati, Domenico Corsi, Antonio Avallone, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|June 27, 2022
[The TAILOR study establishes, in patients mCRC wt, the first line use of FOLFOX in combination with cetuximab]Alfredo Colombo, Gerardo Rosati, Concetta Maria Porretto
In Vivo (Athens, Greece)|February 27, 2026
Appendiceal Tumors: A Narrative ReviewAlfredo Colombo, Vittorio Gebbia, Maria Rosaria Valerio
In Vivo (Athens, Greece)|December 31, 2024
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF MutationAlfredo Colombo, Porretto Maria Concetta, Vittorio Gebbia, et al.
Journal of Clinical Medicine|December 11, 2022
An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal CancerGerardo Rosati, Michele Montrone, Carmen Pacilio, et al.
Oncology|August 21, 2002
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigationVittorio Gebbia, Gaetano Mauceri, Giuseppina Fallica, et al.
Breast Cancer Research and Treatment|February 27, 2003
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinomaVittorio Gebbia, Nicolò Borsellino, Antonio Testa, et al.
Mediators of Inflammation|July 26, 2002
In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytesGabriele Di Lorenzo, Maria Luisa Pacor, Maria Esposito Pellitteri, et al.
Biomedicines|May 28, 2022
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy EfficacyGerardo Rosati, Giuseppe Aprile, Alfredo Colombo, et al.
Mechanisms of Ageing and Development|April 26, 2003
A study of age-related IgE pathophysiological changesGabriele Di Lorenzo, Maria Luisa Pacor, Maria Esposito Pellitteri, et al.
Journal of Geriatric Oncology|October 30, 2021
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT studyGerardo Rosati, Domenico Corsi, Antonio Avallone, et al.
Pageof 2